Nitric oxide, cytochrome c oxidase, and the cellular response to hypoxia

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 30, Issue 4, 2010, Pages 643-647

  Taylor, Cormac T ^a   Moncada, Salvador ^b  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Cytochrome oxidase; Hypoxia; Mitochondria; Nitric oxide; Reactive oxygen species

Indexed keywords

ADENOSINE TRIPHOSPHATE; ADENYLATE KINASE; CYTOCHROME C OXIDASE; HYPOXIA INDUCIBLE FACTOR 1; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; OXYGEN;

BLOOD VESSEL TONE; ENZYME ACTIVITY; HOMEOSTASIS; HUMAN; HYPOXIA; MOLECULAR INTERACTION; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE PHOSPHORYLATION; OXYGEN CONSUMPTION; OXYGEN SENSING; PRIORITY JOURNAL; PROTEIN STABILITY; RESPIRATORY CHAIN; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; BLOOD; BLOOD VESSEL; CELL HYPOXIA; ENZYMOLOGY; METABOLISM; MITOCHONDRION;

ANIMALS; BLOOD VESSELS; CELL HYPOXIA; ELECTRON TRANSPORT COMPLEX IV; HOMEOSTASIS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MITOCHONDRIA; NITRIC OXIDE; OXIDATION-REDUCTION; OXYGEN; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 77950890499     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/ATVBAHA.108.181628     Document Type: Review

References (68)

1. Falkowski PG, Katz ME, Milligan AJ, Fennel K, Aubry MP, Berner RA. Novacek MJ, Zapol WM. The rise of oxygen over the past 205 million years and the evolution of large placental mammals. Science. 2005;309: 2202-2204.
2. Taylor CT, Pouyssegur J. Oxygen, hypoxia and stress. Ann N Y Acad Sci. 2007;1113:87-94.
3. Webster KA. Hypoxia; life on the edge. Antiox Redox Signal. 2007;9: 1303-1307.
4. Spees JL, Olson SD, Whitney MJ, Prockop DJ. Mitochondrial transfer between cells can rescue aerobic respiration. Proc Natl Acad Sci USA. 2006;103:1283-1288.
5. Rich P. The cost of living. Nature. 2003;421:583.
6. Moncada S. Adventures in vascular biology: a tail of two mediators. Phil Trans R Soc B Biol Sci. 2006;361:735-759.
7. Brown GC, Cooper CE. Nanomolar concentrations of nitric oxide reversibly inhibit synaptosomal respiration by competing with oxygen at cytochrome oxidase. FEBS Lett. 1994;356:295-298.
8. Cleeter MW, Cooper JM, Darley-Usmar VM, Moncada S, Schapira AH. Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide. Implications for neuro-degenerative diseases. FEBS Lett. 1994;345:50-54.
9. Schweizer M, Richter C. Nitric oxide potently and reversibly deenergizes mitochondria at low oxygen tension. Biochem Biophys Res Commun. 1994;204:169-175.
10. Cooper CE, Giulivi C. Nitric oxide regulation of mitochondrial oxygen consumption. II: molecular mechanism and tissue physiology. Am J Physiol Cell Physiol. 2007;292:C1993-C2003.
11. Moncada S, Erusalimsky JD. Does nitric oxide modulate mitochondrial energy generation and apoptosis? Nature Rev Mol Cell Biol. 2002;3: 214-220.
12. Ojaimi C, Li W, Kinugawa S, Post H, Csiszar A, Pacher P, Kaley G, Hintze TH. Transcriptional basis for exercise limitation in male eNOS knockout mice with age: heart failure and the fetal phenotype. Am J Physiol Heart Circ Physiol. 2005;289:H1399-H1407.
13. Trochu JN, Bouhour JB, Kaley G, Hintze TH. Role of endothelium-derived nitric oxide in the regulation of cardiac oxygen metabolism: implications in health and disease. Circ Res. 2000;87:1108-1117.
14. Thomas DD, Liu X, Kantrow SP, Lancaster JR Jr. The biological lifetime of nitric oxide: implications for the perivascular dynamics of NO and O2. Proc Natl Acad Sci USA. 2001;98:355-360.
15. Cooper CE, Brown GC. The inhibition of mitochondrial cytochrome oxidase by the gases carbon monoxide, nitric oxide, hydrogen cyanide and hydrogen sulfide: chemical mechanism and physiological consequences. J Bioenerg Biomembr. 2008;40:533-539.
16. Gryglewski RJ, Palmer RMJ, Moncada S. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature. 1986;320:454-456.
17. Liu X, Miller MJ, Joshi MS, Sadowska-Krowicka H, Clark DA, Lancaster JR Jr. Diffusion-limited reaction of free nitric oxide with erythrocytes. J Biol Chem. 1998;273:18709-18713. (Pubitemid 28366253)
18. Brunori M. Nitric oxide moves myoglobin centre stage. Trends Biochem Sci. 2001;26:21-23.
19. O'Donnell VB, Coles B, Lewis MJ, Crews BC, Marnett LJ, Freeman BA. Catalytic consumption of nitric oxide by prostaglandin H synthase-1 regulates platelet function. J Biol Chem. 2000;275:38239-38244.
20. Abu-Soud HM, Hazen SL. Nitric oxide is a physiological substrate for mammalian peroxidases. J Biol Chem. 2000;275:37524-37532.
21. Brunelli L, Yermilov V, Beckman JS. Modulation of catalase peroxidatic and catalatic activity by nitric oxide. Free Rad Biol Med. 2001;30:709-714.
22. Gardner PR, Martin LA, Hall D, Gardner AM. Dioxygen-dependent metabolism of nitric oxide in mammalian cells. Free Rad Biol Med. 2001;31:191-204.
23. Schmidt K, Mayer B. Consumption of nitric oxide by endothelial cells: evidence for the involvement of a NAD(P)H-, flavin-and heme-dependent dioxygenase reaction. FEBS Lett. 2004;577:199-204.
24. Palacios-Callender M, Hollis V, Mitchison M, Frakich N, Unitt D, Moncada S. Cytochrome c oxidase regulates endogenous nitric oxide availability in respiring cells: A possible explanation for hypoxic vasodilation. Proc Natl Acad Sci USA. 2007;104:18508-18513.
25. Pearce LL, Kanai AJ, Birder LA, Pitt BR, Peterson J. The catabolic fate of nitric oxide: the nitric oxide oxidase and peroxynitrite reductase activities of cytochrome oxidase. J Biol Chem. 2002;277:13556-13562.
26. Chance B. Early reduction of cytochrome c in hypoxia. FEBS Lett. 1988;226:343-346.
27. Mills E, Jobsis FF. Mitochondrial respiratory chain of the carotid body and chemoreceptor response to changes in oxygen tension. JNeurophysiol. 1972; 35:405-428.
28. Tamura M. In vivo study of tissue oxygen metabolism using optical and nuclear magnetic resonance spectroscopies. Annu Rev Physiol. 1989;51: 813-834.
29. Ratcliffe PJ, Kaelin WG Jr. Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol Cell. 2008;30:393-402.
30. Taylor CT. Mitochondria and cellular oxygen sensing in the HIF pathway. Biochem J. 2008;409:19-25.
31. Hagen T, Taylor CT, Lam F, Moncada S. Redistribution of intracellular oxygen in hypoxia by nitric oxide:effect on HIF1a. Science. 2003;302: 1975-1978.
32. Mateo J, García-Lecea M, Cadenas S, Hernandez C, Moncada S. Regulation of hypoxia-inducible factor-1a by nitric oxide through mitochondria-dependent and-independent pathways. Biochem J. 2003;376:537-544.
33. Gong Y, Agani FH. Oligomycin inhibits HIF-1a expression in hypoxic tumor cells. Am J Physiol Cell Physiol. 2005;288:1023-1029.
34. Riby JE, Firestone GL, Bjeldanes LF. 3,3'-Diindolylmethane reduces levels of HIF-1 a and HIF-1 activity in hypoxic cultured human cancer cells. Biochem Pharmacol. 2008;75:1858-1867.
35. Brown ST, Nurse CA. Induction of HIF-2a is dependent on mitochondrial O2 consumption in an O2-sensitive adrenomedullary chromaffin cell line. Am J Physiol Cell Physiol. 2008;294:1305-1312.
36. Doege K, Heine S, Jensen I, Jelkmann W, Metzen E. Inhibition of mitochondrial respiration elevates oxygen concentration but leaves regulation of hypoxia inducible factor (HIF) intact. Blood. 2005;106:2311-2317.
37. Victor VM, Nunez C, D'Ocon P, Taylor CT, Esplugues JV, Moncada S. Regulation of oxygen distribution in tissues by nitric oxide. Circ Res. 2009; 104:1178-1183.
38. Galkin A, Higgs EA, Moncada S. Nitric oxide and hypoxia. Essays in Biochemistry-Oxygen Sensing and Hypoxia-Induced Responses, ed. C. Peers. London: Portland Press; 2007:29-42.
39. Mueller CF, Laude K, McNally JS, Harrisson DG. Redox mechanisms in blood vessels. Arterioscler Thromb Vasc Biol. 2005;25:274-278.
40. Hinkle PC, Butow RA, Racker E, Chance B. Partial resolution of the enzymes catalyzing oxidative phosphorylation. XV. Reverse electron transfer in the flavin-cytochrome beta region of the respiratory chain of beef heart submitochondrial particles. J Biol Chem. 1967;242:5169-5173.
41. Boveris A, Chance B. The mitochondrial generation of hydrogen peroxide. General properties and effect of hyperbaric oxygen. Biochem J. 1973;134:707-716.
42. Loschen G, Azzi A, Richter C, Flohe L. Superoxide radicals as precursors of mitochondrial hydrogen peroxide. FEBS Lett. 1974;42:68-72.
43. Boveris A, Cadenas E, Stoppani AO. Role of ubiquinone in the mitochondrial generation of hydrogen peroxide. Biochem J. 1976;156:435-444.
44. Turrens JF, Boveris A. Generation of superoxide anion by the NADH dehydrogenase of bovine heart mitochondria. Biochem J. 1980;191:421-427.
45. Chandel NS, McClintock DS, Feliciano CE, Wood TM, Melendez JA, Rodriguez AM, Schumacker PT. Reactive oxygen species generated at mitochondrial complex III stabilize hypoxia-inducible factor-1a during hypoxia-A mechanism of O2 sensing. J Biol Chem. 2000;275:25130-25138.
46. Guzy RD, Schumacker PT. Oxygen sensing by mitochondria at complex III: the paradox of increased reactive oxygen species during hypoxia. Exp Physiol. 2006;91:807-819.
47. Palacios-Callender M, Quintero M, Hollis V, Springett RJ, Moncada S. Endogenous NO regulates superoxide production at low oxygen concentrations by modifying the redox state of cytochrome c oxidase. Proc Natl Acad Sci USA. 2004;101:7630-7635.
48. Lavrovskya Y, Chatterjeea B, Clark RA, Roy AK. Role of redox-regulated transcription factors in inflammation, aging and age-related diseases. Experiment Gerontol. 2000;35:521-532.
49. Oliver KM, Taylor CT, Cummins EP. Regulation of NF-KB signaling during inflammation: the role of hydroxylases. Arthritis Res Ther. 2009;11:215.
50. Taylor CT. Interdependent roles for hypoxia inducible factor and nuclear factor-KB in hypoxic inflammation. J Physiol. 2008;586:4055-4059.
51. Rius J, Guma M, Schachtrup C, Akassoglou K, Zinkernagel AS, Nizet V, Johnson RS, Haddad GG, Karin M. NF-KB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1a. Nature. 2008;453:807-811.
52. Bowie A, O'Neill LA. Oxidative stress and nuclear factor-KB activation: a reassessment of the evidence in the light of recent discoveries. Biochem Pharmacol. 2000;59:13-23.
53. Chandel NS, Trzyna WC, McClintock DS, Schumacker PT. Role of oxidants in NF-KB activation and TNF-a gene transcription induced by hypoxia and endotoxin. J Immunol. 2000;165:1013-1021.
54. Cummins EP, Berra E, Comerford KM, Fitzgerald KT, Seeballuck F, Godson C, Nielsen JE, Moynagh P, Pouyssegur J, Taylor CT. Prolyl hydroxylase-1 negatively regulates IKK/3 giving new mechanistic insight into hypoxia-induced NFKB activity. Proc Natl Acad Sci USA. 2006; 103:18154-18159.
55. Hardie DG, Carling D. The AMP-activated protein kinase-fuel gauge of the mammalian cell? Eur J Biochem. 1997;246:259-273.
56. Woods A, Dickerson K, Heath R, Hong SP, Momcilovic M, Johnstone SR, Carlson M, and Carling D. Ca2+/calmodulin-dependent protein kinase kinase-/3 acts upstream of AMP-activated protein kinase in mammalian cells. Cell Metab. 2005;2:21-33.
57. Hawley SA, Pan DA, Mustard KJ, Ross L, Bain J, Edelman AM, Fren-guelli BG, Hardie DG. Calmodulin-dependent protein kinase kinase-/3 is an alternative upstream kinase for AMP-activated protein kinase. Cell Metab. 2005;2:9-19.
58. Toyoda T, Hayashi T, Miyamoto L, Yonemitsu S, Nakano M, Tanaka S, Ebihara K, Masuzaki H, Hosoda K, Inoue G, Otaka A, Sato K, Fushiki T, Nakao K. Possible involvement of the a1 isoform of 5'AMP-activated protein kinase in oxidative stress-stimulated glucose transport in skeletal muscle. Am J Physiol Endocrinol Metab. 2004;287:E166-E173.
59. Quintero M, Colombo SL, Godfrey A, Moncada S. Mitochondria as signaling organelles in the vascular endothelium. Proc Natl Acad Sci USA. 2006;103:5379-5384.
60. Erusalimsky J, Moncada S. Nitric oxide and mitochondrial signaling. From physiology to pathophysiology. Arterioscler Thromb Vasc Biol. 2007;27:2524-2531.
61. Colombo SL, Moncada S. AMPKa1 regulates the antioxidant status of vascular endothelial cells. Biochem J. 2009;421:163-169.
62. Mansfield KD, Guzy RD, Pan Y, Young RM, Cash TP, Schumacker PT, Simon MC. Mitochondrial dysfunction resulting from loss of cytochrome c impairs cellular oxygen sensing and hypoxic HIF-a activation. Cell Metab. 2005;1:393-399.
63. Sanjuan-Pla A, Cervera AM, Apostolova N, Garcia-Bou R, Victor VM, Murphy MP, McCreath KJ. A targeted antioxidant reveals the importance of mitochondrial reactive oxygen species in the hypoxic signaling of HIF-a. FEBS Lett. 2005;579:2669-2674.
64. Metzen E, Zhou J, Jelkmann W, Fandrey J, Brune B. Nitric oxide impairs normoxic degradation of HIF-1a by inhibition of prolyl hydroxylases. Mol Biol Cell. 2003;14:3470-3481.
65. Gerald D, Berra E, Frapart YM, Chan DA, Giaccia AJ, Mansuy D, Pouyssegur J, Yaniv M, Mechta-Grigoriou F. JunD reduces tumor angio-genesis by protecting cells from oxidative stress. Cell. 2004;118:781-794.
66. Quintero M, Brennan PA, Thomas GJ, Moncada S. Nitric oxide is a factor in the stabilization of hypoxia-inducible factor-1a in cancer: Role of free radical formation. Cancer Res. 2006;66:770-774.
67. Pouyssegur J, Dayan F, Mazure NM. Hypoxia signalling in cancer and approaches to enforce tumour regression. Nature. 2006;441:437-443.
68. Fraisl P, Aragones J, Carmeliet P. Inhibition of oxygen sensors as a therapeutic strategy for ischaemic and inflammatory disease. Nat Rev Drug Discov. 2009;8:139-152.